These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 2568898
1. A critical review of continuous infusion H2 receptor therapy. Rovers JP, Souney PF. Crit Care Med; 1989 Aug; 17(8):814-21. PubMed ID: 2568898 [Abstract] [Full Text] [Related]
2. A controlled comparison of continuous ranitidine and intermittent famotidine infusions on gastric pH. Bachmann K, Sullivan TJ, Jauregui L. J Clin Pharmacol; 1993 Dec; 33(12):1219-24. PubMed ID: 7907348 [Abstract] [Full Text] [Related]
5. Inhibition of gastric secretion in man with a new H2-receptor antagonist, ranitidine. Kett K, Aadland E, Berstad A. Scand J Gastroenterol; 1980 Dec; 15(2):249-51. PubMed ID: 6104355 [Abstract] [Full Text] [Related]
6. Overnight comparable anacidity by standard large and half-single bedtime doses of H2 antagonists in duodenal ulcer patients: a clinical pharmacological study. Savarino V, Mela GS, Scalabrini P, Sumberaz A, Fera G, Zentilin P, Celle G. Am J Gastroenterol; 1988 Sep; 83(9):917-22. PubMed ID: 2901220 [Abstract] [Full Text] [Related]
8. Achieving pH control in the critically ill patient: the role of continuous infusion of H2-receptor antagonists. Moore JG. DICP; 1990 Nov; 24(11 Suppl):S28-30. PubMed ID: 1980180 [Abstract] [Full Text] [Related]
9. [Comparative studies on hemodynamic effects of intravenous cimetidine, ranitidine and famotidine in intensive care unit patients]. Omote K, Namiki A, Sumita S, Takahashi T, Ujike Y, Hagiwara T. Masui; 1987 Jun; 36(6):940-7. PubMed ID: 2888909 [No Abstract] [Full Text] [Related]
11. Bolus or intravenous infusion of ranitidine: effects on gastric pH and acid secretion. A comparison of relative efficacy and cost. Ballesteros MA, Hogan DL, Koss MA, Isenberg JI. Ann Intern Med; 1990 Mar 01; 112(5):334-9. PubMed ID: 2306061 [Abstract] [Full Text] [Related]
12. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease. Hatlebakk JG, Berstad A. Clin Pharmacokinet; 1996 Nov 01; 31(5):386-406. PubMed ID: 9118586 [Abstract] [Full Text] [Related]
15. Use of continuous infusion of histamine2-receptor antagonists in critically ill patients. Siepler JK, Trudeau W, Petty DE. DICP; 1989 Oct 01; 23(10 Suppl):S40-3. PubMed ID: 2573209 [Abstract] [Full Text] [Related]
16. Considerations for selection of parenteral histamine (H2)-receptor antagonists. Wolfe MM. Am J Med; 1987 Dec 18; 83(6A):82-8. PubMed ID: 2892411 [Abstract] [Full Text] [Related]
17. A dosage alternative for H2-receptor antagonists--constant infusion. Siepler JK. Clin Ther; 1986 Dec 18; 8 Suppl A():24-33. PubMed ID: 2878728 [Abstract] [Full Text] [Related]